Gyon Technologies Capital Management, LP Vera Therapeutics, Inc. Transaction History

Gyon Technologies Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$15.74 - $22.19 $173,423 - $244,489	-11,018 Reduced 53.93%	9,413 $182,000
Q3 2022 Nov 14, 2022	BUY	$13.27 - $22.31 $271,119 - $455,815	20,431 New	20,431 $435,000
Q2 2022 Aug 15, 2022	SELL	$12.82 - $23.4 $217,440 - $396,887	-16,961 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$17.8 - $28.06 $135,137 - $213,031	-7,592 Reduced 30.92%	16,961 $398,000
Q4 2021 Feb 11, 2022	BUY	$15.01 - $35.8 $82,720 - $197,293	5,511 Added 28.94%	24,553 $656,000
Q3 2021 Nov 18, 2021	BUY	$13.71 - $30.6 $261,065 - $582,685	19,042 New	19,042 $330,000

185

55.6M

134K

156K

Ticker VERA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,042,300
Market Cap $1.03B
Description
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.